Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus. Ostendorf L, Burns M, Durek P, Heinz GA, et al. N Engl J Med 2020;383:1149-1155.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ostendorf L, Burns M, Durek P, Heinz GA, et al. Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus. N Engl J Med 2020;383:1149-1155.
PMID: 32937047